Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 9
2019 23
2020 18
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Results by year
Filters applied: . Clear all
Page 1
Immune Checkpoint Inhibitors-Induced Hepatitis.
Tian Y, Abu-Sbeih H, Wang Y. Tian Y, et al. Among authors: abu sbeih h. Adv Exp Med Biol. 2018;995:159-164. doi: 10.1007/978-3-030-02505-2_8. Adv Exp Med Biol. 2018. PMID: 30539511 Review.
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events.
Brahmer JR, Abu-Sbeih H, Ascierto PA, Brufsky J, Cappelli LC, Cortazar FB, Gerber DE, Hamad L, Hansen E, Johnson DB, Lacouture ME, Masters GA, Naidoo J, Nanni M, Perales MA, Puzanov I, Santomasso BD, Shanbhag SP, Sharma R, Skondra D, Sosman JA, Turner M, Ernstoff MS. Brahmer JR, et al. Among authors: abu sbeih h. J Immunother Cancer. 2021 Jun;9(6):e002435. doi: 10.1136/jitc-2021-002435. J Immunother Cancer. 2021. PMID: 34172516 Free PMC article.
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis.
Wang Y, Wiesnoski DH, Helmink BA, Gopalakrishnan V, Choi K, DuPont HL, Jiang ZD, Abu-Sbeih H, Sanchez CA, Chang CC, Parra ER, Francisco-Cruz A, Raju GS, Stroehlein JR, Campbell MT, Gao J, Subudhi SK, Maru DM, Blando JM, Lazar AJ, Allison JP, Sharma P, Tetzlaff MT, Wargo JA, Jenq RR. Wang Y, et al. Among authors: abu sbeih h. Nat Med. 2018 Dec;24(12):1804-1808. doi: 10.1038/s41591-018-0238-9. Epub 2018 Nov 12. Nat Med. 2018. PMID: 30420754 Free PMC article.
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease.
Abu-Sbeih H, Faleck DM, Ricciuti B, Mendelsohn RB, Naqash AR, Cohen JV, Sellers MC, Balaji A, Ben-Betzalel G, Hajir I, Zhang J, Awad MM, Leonardi GC, Johnson DB, Pinato DJ, Owen DH, Weiss SA, Lamberti G, Lythgoe MP, Manuzzi L, Arnold C, Qiao W, Naidoo J, Markel G, Powell N, Yeung SJ, Sharon E, Dougan M, Wang Y. Abu-Sbeih H, et al. J Clin Oncol. 2020 Feb 20;38(6):576-583. doi: 10.1200/JCO.19.01674. Epub 2019 Dec 4. J Clin Oncol. 2020. PMID: 31800340 Free PMC article.
Hepatobiliary Adverse Events.
Abu-Sbeih H, Wang Y. Abu-Sbeih H, et al. Adv Exp Med Biol. 2020;1244:271-276. doi: 10.1007/978-3-030-41008-7_14. Adv Exp Med Biol. 2020. PMID: 32301021 Review.
Gastrointestinal Tract Adverse Events.
Abu-Sbeih H, Wang Y. Abu-Sbeih H, et al. Adv Exp Med Biol. 2020;1244:247-253. doi: 10.1007/978-3-030-41008-7_12. Adv Exp Med Biol. 2020. PMID: 32301019 Review.
Immune Checkpoint Inhibitors-Induced Colitis.
Tian Y, Abu-Sbeih H, Wang Y. Tian Y, et al. Among authors: abu sbeih h. Adv Exp Med Biol. 2018;995:151-157. doi: 10.1007/978-3-030-02505-2_7. Adv Exp Med Biol. 2018. PMID: 30539510 Review.
Reply to Y. Inagaki et al.
Abu-Sbeih H, Faleck DM, Dougan M, Wang Y. Abu-Sbeih H, et al. J Clin Oncol. 2020 May 20;38(15):1749-1750. doi: 10.1200/JCO.20.00295. Epub 2020 Apr 6. J Clin Oncol. 2020. PMID: 32250720 No abstract available.
Reply to J. Delyon et al.
Abu-Sbeih H, Ali FS, Owen DH, Ricciuti B, Naqash AR, Wang Y. Abu-Sbeih H, et al. J Clin Oncol. 2019 Dec 20;37(36):3564-3565. doi: 10.1200/JCO.19.02133. Epub 2019 Oct 9. J Clin Oncol. 2019. PMID: 31596634 No abstract available.
50 results